We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPID icon
11051
Rapid Micro Biosystems
RPID
$84.3M
$128K ﹤0.01%
+29,713
New +$138K
ACCD
11052
DELISTED
Accolade Inc
ACCD
$128K ﹤0.01%
17,220
-248,827
-94% -$2.18M
ASTR
11053
PUT
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$128K ﹤0.01%
6,540
+527
+9% +$21.5K
CHIR
11054
DELISTED
Global X MSCI China Real Estate ETF
CHIR
$128K ﹤0.01%
4,237
-793
-16% -$22.7K
ACII.U
11055
DELISTED
Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant
ACII.U
$128K ﹤0.01%
13,032
-115
-0.9% -$1.13K
BIRD icon
11056
PUT
Smartbird Inc
BIRD
$30.1M
$127K ﹤0.01%
1,620
-5,250
-76% -$530K
CLEU
11057
DELISTED
China Liberal Education Holdings
CLEU
$127K ﹤0.01%
12
+11
+1,100% +$290K
DIBS icon
11058
PUT
1stdibs.com
DIBS
$165M
$127K ﹤0.01%
+22,400
New +$147K
YSG
11059
CALL
Yatsen Holding
YSG
$319M
$127K ﹤0.01%
16,420
-320
-2% -$1.09K
CNSL
11060
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$127K ﹤0.01%
+18,100
New +$119K
DRD
11061
CALL
DRDGold
DRD
$2.1B
$126K ﹤0.01%
21,500
-35,900
-63% -$266K
SVIX icon
11062
PUT
-1x Short VIX Futures ETF
SVIX
$173M
$126K ﹤0.01%
+12,100
New +$139K
BTX
11063
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
$126K ﹤0.01%
+15,841
New +$142K
OSG
11064
CALL
DELISTED
Overseas Shipholding Group Inc.
OSG
$126K ﹤0.01%
61,700
-7,400
-11% -$15.9K
TGR.WS
11065
DELISTED
Kimbell Tiger Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TGR.WS
$126K ﹤0.01%
+697,805
New +$157K
ASX icon
11066
CALL
ASE Group
ASX
$103B
$125K ﹤0.01%
24,100
-12,500
-34% -$83.3K
BRLT icon
11067
PUT
Brilliant Earth
BRLT
$22.5M
$125K ﹤0.01%
26,300
-62,500
-70% -$392K
IAG icon
11068
PUT
IAMGOLD
IAG
$10.4B
$125K ﹤0.01%
77,900
-17,100
-18% -$43K
TV icon
11069
CALL
Televisa
TV
$1.53B
$125K ﹤0.01%
15,300
-12,200
-44% -$115K
ORKA
11070
PUT
Oruka Therapeutics
ORKA
$7.35B
$125K ﹤0.01%
4,175
+3,142
+304% +$88.8K
VBIV
11071
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$125K ﹤0.01%
5,150
+1,013
+24% +$34.5K
CELL
11072
CALL
DELISTED
PhenomeX Inc. Common Stock
CELL
$125K ﹤0.01%
25,100
-16,000
-39% -$83.8K
ZEV
11073
PUT
DELISTED
Lightning eMotors, Inc.
ZEV
$125K ﹤0.01%
2,255
-415
-16% -$33K
IMMR icon
11074
Immersion
IMMR
$249M
$124K ﹤0.01%
23,230
-82,336
-78% -$427K
LUXE
11075
LuxExperience B.V.
LUXE
$1.05B
$124K ﹤0.01%
12,588
-16,470
-57% -$186K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.